Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: Comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2419-2425

  Gnanashanmugam, Devasena ^a   Falkovitz Halpern, Meira S ^a   Dodge, Anthony ^a,b   Fang, Melanie ^a,b   Wong, Lisa J ^a,b   Esparza, Melissa ^a   Hammon, Rebecca ^a,c   Rivas Merelles, Enrique E ^a,d   Santos, Jose I ^a,e   Maldonado, Yvonne ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University School of Medicine ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hospital Regional de Rio Blanco   (Mexico)

^e HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; NUCLEOTIDE; ORAL POLIOMYELITIS VACCINE; URACIL;

ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; MEXICO; MONITORING; MUTANT ANALYSIS BY POLYMERASE CHAIN REACTION AND ENZYME CLEAVAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VACCINE ASSOCIATED PARALYTIC POLIOMYELITIS; VIRUS SHEDDING;

FECES; HUMANS; MEXICO; POINT MUTATION; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS SHEDDING;

POLIOVIRUS;

EID: 34548067153     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02268-06     Document Type: Article

References (29)

1. Andrus, J. K., P. M. Strebel, C. A. de Quadros, and J. M. Olive. 1995. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull. W. H. O. 73:33-40.
2. Blume, S., and I. Geesink. 2000. A brief history of polio vaccines. Science 288:1593-1594.
3. Buonagurio, D. A., J. W. Coleman, S. A. Patibandla, B. S. Prabhakar, and J. M. Tatem. 1999. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method. J. Clin. Microbiol. 37:283-289.
4. Bustin, S. A. 2002. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29:23-39.
5. Centers for Disease Control and Prevention. 2001. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus - Philippines, 2001. Morb. Mortal. Wkly. Rep. 50:874-875.
6. Centers for Disease Control and Prevention. 2001. Circulation of a type 2 vaccine-derived poliovirus - Egypt, 1982-1993. Morb. Mortal. Wkly. Rep. 50:41-42, 51.
7. Centers for Disease Control and Prevention. 1997. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. Recomm. Rep. 46:1-25.
8. Chumakov, K. 2000. Mutant analysis by PCR and restriction enzyme cleavage (MAPREC) for oral poliovirus (Sabin) vaccine: standard operating procedure. World Health Organization (WHO) collaborative study on MAPREC, vol. 3.4, p. 1-27. World Health Organization, Geneva, Switzerland.
9. Evans, D. M., G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann, G. Stanway, J. W. Almond, K. Currey, and J. V. Maizel, Jr. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:548-550.
10. Friedrich, F. 1996. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Acta Virol. 40:157-170.
11. Glaab, W. E., and T. R. Skopek. 1999. A novel assay for allelic discrimination that combines the fluorogenic 5′ nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay. Mutat. Res. 430:1-12.
12. Kew, O., V. Morris-Glasgow, M. Landaverde, C. Burns, J. Shaw, Z. Garib, J. Andre, E. Blackman, C. J. Freeman, J. Jorba, R. Sutter, G. Tambini, L. Venczel, C. Pedreira, F. Laender, H. Shimizu, T. Yoneyama, T. Miyamura, H. van Der Avoort, M. S. Oberste, D. Kilpatrick, S. Cochi, M. Pallansch, and C. de Quadros. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356-359.
13. Kew, O. M., B. K. Nottay, M. H. Hatch, J. H. Nakano, and J. F. Obyeski. 1981. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J. Gen. Virol. 56:337-347.
14. Kew, O. M., P. F. Wright, V. I. Agol, F. Delpeyroux, H. Shimizu, N. Nathanson, and M. A. Pallansch. 2004. Circulating vaccine-derived polioviruses: current state of knowledge. Bull. W. H. O. 82:16-23.
15. Kim-Farley, R. J., K. J. Bart, L. B. Schonberger, W. A. Orenstein, B. M. Nkowane, A. R. Hinman, O. M. Kew, M. H. Hatch, and J. E. Kaplan. 1984. Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet 2:1315-1317.
16. Laassri, M., K. Lottenbach, R. Belshe, M. Rennels, S. Plotkin, and K. Chumakov. 2006. Analysis of reversions in the 5′-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. J. Infect. Dis. 193:1344-1349.
17. Laassri, M., K. Lottenbach, R. Belshe, M. Wolff, M. Rennels, S. Plotkin, and K. Chumakov. 2005. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J. Infect. Dis. 192:2092-2098.
18. Li, B., I. Kadura, D. J. Fu, and D. E. Watson. 2004. Genotyping with TaqMAMA. Genomics 83:311-320.
19. Maldonado, Y. A., V. Pena-Cruz, M. de la Luz Sanchez, L. Logan, S. Blandon, M. F. Cantwell, S. M. Matsui, F. Millan-Velasco, J. L. Valdespino, and J. Sepulveda. 1997. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J. Infect. Dis. 175:545-553.
20. Martinez, C. V., M. O. Old, D. K. Kwock, S. S. Khan, J. J. Garcia, C. S. Chan, R. Webster, M. S. Falkovitz-Halpern, and Y. A. Maldonado. 2004. Shedding of Sabin poliovirus type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J. Infect. Dis. 190:409-416.
21. Minor, P. D., and G. Dunn. 1988. The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J. Gen. Virol. 69(Pt. 5):1091-1096.
22. Minor, P. D., G. Dunn, M. E. Ramsay, and D. Brown. 2005. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J. Med. Virol. 75:153-160.
23. Old, M. O., C. V. Martinez, D. Kwock, J. Garcia, G. Martin, C. Chan, and Y. A. Maldonado. 2003. Direct extraction of Sabin poliovirus genomes from human fecal samples using a guanidine thiocyanate extraction method. J. Virol. Methods 110:193-200.
24. Parent du Chatelet, I., A. T. Merchant, S. Fisher-Hoch, S. P. Luby, S. A. Plotkin, T. Moatter, M. Agboatwalla, and J. B. McCormick. 2003. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine 21:1710-1718.
25. Rousset, D., M. Rakoto-Andrianarivelo, R. Razafindratsimandresy, B. Randriamanalina, S. Guillot, J. Balanant, P. Mauclere, and F. Delpeyroux. 2003. Recombinant vaccine-derived poliovirus in Madagascar. Emerg. Infect. Dis. 9:885-887.
26. Sabin, A. B., M. Ramos-Alvarez, J. Alvarez-Amezquita, W. Pelon, R. H. Michaels, I. Spigland, M. A. Koch, J. M. Barnes, and J. S. Rhim. 1960. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA 173:1521-1526.
27. Samoilovich, E., M. Roivainen, L. P. Titov, and T. Hovi. 2003. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children. J. Med. Virol. 71:274-280.
28. Svitkin, Y. V., N. Cammack, P. D. Minor, and J. W. Almond. 1990. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472 - U. Virology 175:103-109.
29. Trujillo, A. A., K. A. McCaustland, D. P. Zheng, L. A. Hadley, G. Vaughn, S. M. Adams, T. Ando, R. I. Glass, and S. S. Monroe. 2006. Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of Norovirus. J. Clin. Microbiol. 44:1405-1412.